India · Delayed Price · Currency is INR Mangalam Drugs & Organics Statistics
Total Valuation
BOM:532637 has a market cap or net worth of INR 1.17 billion. The enterprise value is 2.11 billion.
| Market Cap | 1.17B |
| Enterprise Value | 2.11B |
Important Dates
The last earnings date was Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:532637 has 15.83 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 15.83M |
| Shares Outstanding | 15.83M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +6.56% |
| Owned by Insiders (%) | 22.30% |
| Owned by Institutions (%) | n/a |
| Float | 7.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.39 |
| PB Ratio | 0.79 |
| P/TBV Ratio | 1.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -21.62 |
| EV / Sales | 0.71 |
| EV / EBITDA | 8.29 |
| EV / EBIT | 35.57 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.65 |
| Debt / EBITDA | 3.78 |
| Debt / FCF | n/a |
| Interest Coverage | 0.39 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 1.52% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 6.90M |
| Profits Per Employee | -225,977 |
| Employee Count | 432 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:532637 has paid 9.65 million in taxes.
| Income Tax | 9.65M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.07% in the last 52 weeks. The beta is 0.04, so BOM:532637's price volatility has been lower than the market average.
| Beta (5Y) | 0.04 |
| 52-Week Price Change | -44.07% |
| 50-Day Moving Average | 83.79 |
| 200-Day Moving Average | 92.56 |
| Relative Strength Index (RSI) | 36.63 |
| Average Volume (20 Days) | 7,269 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:532637 had revenue of INR 2.98 billion and -97.62 million in losses. Loss per share was -6.17.
| Revenue | 2.98B |
| Gross Profit | 1.32B |
| Operating Income | 59.34M |
| Pretax Income | -87.97M |
| Net Income | -97.62M |
| EBITDA | 254.71M |
| EBIT | 59.34M |
| Loss Per Share | -6.17 |
Balance Sheet
The company has 25.89 million in cash and 962.30 million in debt, giving a net cash position of -936.41 million or -59.16 per share.
| Cash & Cash Equivalents | 25.89M |
| Total Debt | 962.30M |
| Net Cash | -936.41M |
| Net Cash Per Share | -59.16 |
| Equity (Book Value) | 1.49B |
| Book Value Per Share | 100.32 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 44.17%, with operating and profit margins of 1.99% and -3.27%.
| Gross Margin | 44.17% |
| Operating Margin | 1.99% |
| Pretax Margin | -2.95% |
| Profit Margin | -3.27% |
| EBITDA Margin | 8.54% |
| EBIT Margin | 1.99% |
| FCF Margin | n/a |
Dividends & Yields
BOM:532637 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | n/a |
| Earnings Yield | -8.31% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |